Plasma concentrations of disodium cromoglycate after various inhalation methods in healthy subjects

British Journal of Clinical Pharmacology

Volumn 48, Issue 2, 1999, Pages 154-157

  Kato, Yasuhiro ^a,b   Muraki, K ^a   Fujitaka, M ^a   Sakura, N ^a   Ueda, K ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

Aerosol; Disodium cromoglycate; Isotonic saline; Plasma concentration; Procaterol solution; Reversed phase high performance liquid chromatography; Ultrasonic nebuliser

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CROMOGLYCATE DISODIUM; PROCATEROL; SODIUM CHLORIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INHALATION; INHALATIONAL DRUG ADMINISTRATION; MALE; NEBULIZATION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INHALATION; ADULT; AEROSOLS; ANTI-ASTHMATIC AGENTS; AREA UNDER CURVE; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROMOLYN SODIUM; FEMALE; HUMANS; MALE; NEBULIZERS AND VAPORIZERS;

EID: 0032769340     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1999.00979.x     Document Type: Article

References (12)

1. 1 Sheard P, Blair AMJN. Disodium cromoglycate activity in three in vivo models of the immediate hypersensitivity reaction in lung. Int Arch Allergy Appl Immunol 1970; 38: 217-224.
2. 2 Bernard AB. Cromolyn; past, present, and future. Pediatr Clin North Am 1983; 30: 915-930.
3. 3 Terry WC, Eliezer N. Detrimental effect of hypotonic cromolyn sodium. J Pediatr 1992; 120: 641-643.
4. 4 Obata T, Matsuda S, Akasawa A, et al. Preventive effect and duration of action of disodium cromoglycate and procaterol on exercise-induced asthma in asthmatic children. Ann Allergy 1993; 70: 123-126.
5. 5 Tillman J, Whymark DW. A method for the determination of disodium cromoglycate and other chromones. Anal 1971; 96: 689-698.
6. 6 Curry SH, Mills GG. A note on the analysis of disodium cromoglycate (Intal) in human urine. J Pharm Pharmacol 1973; 25: 677-678.
7. 7 Fuller RW, Collier JG. The pharmacokinetic assessment of sodium cromoglycate. J Pharm Pharmacol 1983; 35: 289-292.
8. 8 Neale MG, Brown K, Hodder RW, et al. The pharmacokinetics of sodium cromoglycate in man after intravenous and inhalation administration. Br J Clin Pharmacol 1986; 22: 373-382.
9. 9 Dolovich M, Obminski G, Cockcroft DW, et al. Standardisation of inhalation tests. Influence of method of aerosol generation and inhalation. J Allergy Clin Immunol 1979; 63: 165.
10. 10 Newman SP, Pavia D, Clarke SW. How should a pressurised β-adrenergic bronchodilator be inhaled? Eur J Resp Dis 1981; 62: 3-21.
11. 11 Patel KR, Tullett WM, Neale MG, et al. Plasma concentrations of sodium cromoglycate given by nebulisation and metered dose inhalers in patients with exercise induced asthma; relationship to protective effect. Br J Clin Pharmacol 1986; 21: 231-233.
12. 12 Yahav Y, Dany S, Katznelson D, et al. Sodium cromoglycate in asthma: correlation between response and serum concentrations. Arch Dis Child 1988; 63: 592-597.